Accuray :: Robotic Radiosurgery Solution

Accuray is a global leader in advanced radiotherapy solutions, dedicated to expanding the curative power of radiation therapy through innovative, precise technologies that improve patient outcomes and quality of life. With thousands of systems installed worldwide, Accuray focuses on delivering personalized, effective treatments for cancer and other conditions while prioritizing efficiency, safety, and accessibility in clinical settings. The company designs market-changing systems that address complex challenges and streamline common cases, supported by a strong emphasis on AI integration, real-time motion management, and clinical evidence.

At the heart of Accuray‘s offerings are its robotic and advanced radiation delivery platforms. The CyberKnife® S7™ system stands out as a flagship robotic radiosurgery solution. It delivers stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) anywhere in the body with unmatched precision. This fully robotic system tracks and synchronizes with tumor motion in real-time using AI-driven capabilities, adapting to patient movement without the need for invasive frames or breath-holding. It enables highly conformal dose delivery to tumors while sparing healthy tissue, making it ideal for treating prostate, lung, brain, spine, and other challenging cases. The system’s flexibility and accuracy allow for hypofractionated treatments, reducing sessions and improving patient comfort.

Complementing this is the Radixact® system, which expands patient-first treatment options through helical tomotherapy. It features integrated 3D kVCT and MVCT imaging for superior image-guided intensity-modulated radiation therapy (IG-IMRT) and 3D conformal radiation therapy (3DCRT). The platform supports adaptive radiotherapy workflows, allowing clinicians to adjust plans based on daily anatomical changes. ClearRT™ imaging technology further enhances visualization and shortens treatment times. Together, these systems provide a comprehensive suite for precise, efficient care across a spectrum of indications.

Accuray also offers the Accuray Helix™ and other innovations that emphasize interoperability, AI applications in radiation oncology, and responsible deployment of advanced tools. Their solutions prioritize quality of care, treatment efficiency, and clinician confidence. A companion robot like Miroki demonstrates their broader commitment to patient-centered innovations, particularly for pediatric radiotherapy. The company maintains robust service support, training, and a peer community (Accuray Exchange) for ongoing clinical collaboration and education.

With a global presence, Accuray continues to drive advancements in radiation oncology through research, partnerships, and advocacy initiatives like WRAD (World Radiotherapy Awareness Day). Their systems, built with a high percentage of U.S.-sourced components, support thousands of patients daily by enabling precise, non-invasive treatments that minimize side effects and accelerate recovery. Accuray‘s focus on innovation helps clinicians tackle complex tumors while making routine treatments more accessible and effective worldwide.